Blueclinical

BlueClinical is a Lisbon-based, private CRO founded in 2018, operating in the Digital Health and Diagnostics sectors. It provides specialized services for Bioequivalence and Phase I clinical trials with both healthy and patient participants, emphasizing translational medicine consultancy. The company is recognized by the Portuguese National Innovation Agency (ANI) and is a founding member of the larger Astrum CRO network, which expands its service offerings and European reach. Its business model is service-based, generating revenue from clinical trial management and consulting.

Integrated clinical trial services platform specializing in Bioequivalence and Phase I studies, with consultancy in translational medicine. Utilizes clinical trial management systems and operational expertise rather than a proprietary product.

Operates in the highly competitive global CRO market, competing against large players (e.g., IQVIA, Parexel) and numerous regional specialists. Differentiates through a focused niche in early-phase/BE studies, translational medicine consultancy, and its affiliation with the Astrum European network.